Scientists Are Worried About A Collapse Of This Atlantic Ocean Current: Here's Why
Climatologist and oceanographer at the National Research Center, Sandro Carniel, explained the AMOC's function to Renewable Matter. "This circulation, of which the Gulf Stream is a part, plays the fundamental role of a climate equalizer and is essentially triggered by the weight of water, its density. The colder and saltier the water is, the greater its density, and the easier it is for its mass to sink. Whereas if the water is warm and fresh (i.e., not salty), it is lighter and therefore stays at the surface more."
The extreme importance of the AMOC is being threatened by greenhouse gas emissions, a driving force in global warming. Global warming would be a direct contributor to an AMOC collapse. If this is not prevented, the consequences could be catastrophic and include drastic temperature changes, altered weather patterns, and even an ice age event.
Read more: This Is How Most Life On Earth Will End
Why Would This Atlantic Current Collapse?
Global warming is disrupting the way the currents flow due to melting ice caps and glaciers. Carniel continued to explain to Renewable Matter, "The huge amounts of melting ice are pouring an incredible amount of fresh water into the North Atlantic. Less and less salty and warmer waters are helping to lag the general circulation of currents."
This is not a new or sudden phenomenon. In 2018, the journal Nature revealed that the buoyancy of the Atlantic Meridional Overturning Circulation had decreased by 15 percent over 70 years.
While the AMOC has been affected due to global warming, it has not collapsed yet. To prevent this, greenhouse gas emissions need to be massively reduced. Industrial and manufacturing activities, transportation, and animal agriculture are all driving forces behind large amounts of greenhouse gas emissions. Despite efforts to implement better renewable energy and cleaner practices, the UN claims we are failing at attempts to control climate change.
What Would Happen If The AMOC Collapsed?
If the AMOC collapsed, European cities would get colder by up to 27 degrees within a few decades. So a temperature of 41 degrees could drop to 14. Comparatively, the Southern Hemisphere would get much warmer. Rising sea levels could send coastal regions underwater and also contribute to increased coastal erosion and more severe storm surges.
The impact on weather patterns would be widespread. Europe would experience more violent storms. Major droughts would plague Asia. The changing weather would drastically reduce crop yield, and a full ecosystem collapse could occur across the northern Atlantic.
Scientists have a historical reference point for such an event. About 12,900 years ago, the AMOC was halted when Lake Agassiz melted and unleashed massive amounts of freshwater into the sea. It's believed the lake's melting was caused by a comet. The subsequent halt of the AMOC caused over one thousand years of ice age conditions in parts of Europe and North America. Unless we are able to get a handle on global warming and protect the Atlantic Meridional Overturning Circulation, this could be the future we have to prepare for.
Read the original article on BGR.
Solve the daily Crossword
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNET
3 hours ago
- CNET
This Nature App Uses AI to Turn Anyone Into a Wildlife Expert. Here's How to Get Started
When I recently moved, one of the building's standout features was the plethora of different plant species in front of its windows. But not like standard landscaping -- more like drier plants, seemingly native to the area. Curious and fairly incompetent in plant sciences, I looked for help in being able to categorize and understand more about it. That's how I found Seek by iNaturalist, a free app where you take photos of plants, animals and fungi. Artificial intelligence suggests its type -- with human confirmation -- while your input and contributions elevate scientific research. What is Seek and how does it use AI? Founded in 2008 as a master's project from UC Berkeley students, iNaturalist later became a joint initiative between the California Academy of Sciences and the National Geographic Society. It strives to connect people to nature and conservation through crowdsourced data. Today, it contains more than 250 million observations of more than a half-million species. (And I just added seven more in roughly 5 minutes.) Seek by iNaturalist is 100% free thanks to donors who contributed to the platform. It operates as a nonprofit organization that makes all collected data -- with the option to turn it off -- openly accessible to scientists and conservationists worldwide. iNaturalist uses computer vision AI to analyze uploaded photos against a model trained on millions of previous observations. AI is also used on the back end -- it optimizes species recognition accuracy, to display the most relevant photos alongside suggestions and pattern recognition improvements. This helps you distinguish between similar-looking species at home or across your local ecosystems. According to the iNaturalist team, "When you use the AI camera feature on any wild living thing, iNaturalist suggests an identification for what you might be seeing -- whether plant, insect, fungus or other organism." They shared that from there, that photo becomes a useful piece of data for science and conservation. But ultimately, a community of naturalists confirm or correct those AI suggestions. Together, AI and human intelligence help newcomers contribute to biodiversity documentation from their first upload. How to use iNaturalist to spot and categorize nature 1. First search for Seek in your app store of choice and create an account by signing up with email or a social media authenticator. You'll also need to allow camera and location permissions to be able to use the AI's computer vision and accurately detect species. 2. It's best to play around a bit before starting scans. Open the app and tap the camera button -- it's designed to recognize any plant, animal and fungi. I focused solely on plants, as that's what I had readily available. Snap a couple photos or hold the camera button down to snap continuously. Using iNaturalist's AI camera to identify a plant species. Screenshot by CNET As you're testing the camera out, note background images, angles and even lighting, which all play a part in the AI tool's ability to accurately recognize what you've captured. (I had to redo a couple because an attempt to take a birds-eye shot ended up with pictures of my feet.) 3. Next, the AI computer vision will analyze your photo and suggest possible species. This takes no longer than 30 seconds. Here you can also record GPS coordinates and you have the option to add details about behavior, size and other aspects of whatever it is you observed and captured. Beyond this, you can also toggle between privacy options, and select whether it is captive, like a plant, or wild, like natural growth. 4. AI also has suggestions for your species identification, which show up as percentages for accuracy. You can also post your observation -- if geoprivacy is open -- to the community for review by users and experts, like scientists. Once the community confirms your species, your observation becomes scientific data. The point here is that you are part of the collection process for scientists to learn more about species in the world. With your input and the community's approval, you're directly involved in this process. Think of yourself as a bridge between reality and what scientists are constantly trying to understand and improve. The iNaturalist team provided tips for getting the best results, alongside checking out their company guides, or downloading the Seek user guide: treat AI suggestions as a starting point, and engage with other humans; explore information on iNaturalist's database; and be aware that there are more advanced camera suggestions in the iPhone app over the Android app. Should you use iNaturalist? The app is designed like Instagram for nature lovers, with a volunteer process that positions itself as additional help for scientists' discoveries. In my opinion, technology that helps connect people to nature and advances scientific understanding is inherently valuable for our planet and future generations. Some of the privacy options available on the iNaturalist Seek app when you upload your observations. iNaturalist / Screenshot by CNET But even though Seek operates globally, with 3.7 million users, the identification accuracy depends heavily on having active expert communities in your region. This means rural or less-populated areas might get slower species confirmations. Additionally, the topic of AI ethics comes to mind. I asked the iNaturalist team about this. They responded that the location is important for information when correctly identifying species, especially wild ones. Yet they also noted that anyone using iNaturalist can "choose to obscure the precise locations of observations to protect their privacy" and that you can use the AI identification feature without creating an account or posting publicly. The iNaturalist team also regularly updates the Privacy Policy in support of the well-being of the community. The main goal is to create an open biodiversity dataset that can be used to protect nature around the world. Overall, Seek by iNaturalist is a great way to educate yourself and contribute to multiple versions of ecosystems in the process while learning and sharing your findings along the way -- or, as the iNaturalist team shared, a "virtuous cycle of collective effort and improvement, built on community trust and benefit in service of helping people connect with nature and biodiversity worldwide."
Medscape
6 hours ago
- Medscape
These Markers May Predict Risk for Bone Loss in SLE
TOPLINE: Osteoporosis was prevalent in 41% of patients with systemic lupus erythematosus (SLE). Factors such as lupus nephritis classes III and IV, U1-ribonucleoprotein (RNP) antibodies, and longer disease duration were associated with lower areal bone mineral density (BMD), and active lupus nephritis was associated with osteoporosis. METHODOLOGY: Researchers analysed data of a subcohort of patients from a prospective observational study to identify factors associated with BMD and the risk for osteoporosis. They included 110 patients with SLE (mean age, 48 years; 92% women) from a hospital in Berlin between July 2015 and January 2022 who fulfilled the American College of Rheumatology/ European League Against Rheumatism 2019 SLE classification criteria and had current or prior glucocorticoid treatment. The analysis included SLE disease activity and a standardised bone health assessment with the DEXA scan and trabecular bone score measurement according to national guidelines. BMD- and osteoporosis-related factors were assessed. The following three co-primary endpoints were assessed: Areal BMD, expressed as the lowest DEXA-derived T score at the lumbar spine (L1-L4), total hip, or femoral neck A composite osteoporosis outcome (a femoral or lumbar spine T score ≤ -2.5 and/or history of a major fragility fracture and/or antiosteoporotic treatment) The prevalence of fragility fractures (any, vertebral, and non-vertebral). TAKEAWAY: Overall, 41% and 35% of patients with SLE had osteoporosis and lupus nephritis, respectively. Factors significantly associated with lower areal BMD included lupus nephritis classes III and IV (P = .025), U1-RNP antibodies (P = .009), higher C-reactive protein levels (P = .015), and longer disease duration (P = .001). Clinical remission (P = .033) and higher Health Assessment Questionnaire scores (P = .009) were positively correlated with areal BMD. Active lupus nephritis was strongly associated with osteoporosis in patients with SLE (odds ratio [OR], 7.42; P = .027), along with other factors such as older age (OR, 1.06; P = .003) and lower Health Assessment Questionnaire scores (OR, 0.29; P = .005). IN PRACTICE: "The identification of SLE-specific risk factors allows us to recognize patients at particular high risk for OP [osteoporosis]. This prompts us to suggest a thorough osteoporosis check-up in patients with high CRP [C-reactive protein], LN [lupus nephritis], or U1-RNP-antibodies," the authors wrote. SOURCE: This study was led by Edgar Wiebe, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Rheumatology and Clinical Immunology, Charitéplatz 1, Berlin, Germany. It was published online on July 28, 2025, in Arthritis Research & Therapy. LIMITATIONS: This monocentric cohort study primarily involved White Caucasians, thereby limiting the generalisability of the findings to other patient groups. A potential selection bias may have resulted in overrepresentation of patients with more severe disease courses who were at a high risk for osteoporosis. The cross-sectional design limited the ability to establish causality between identified factors and outcomes. DISCLOSURES: Open access funding was enabled and organised by Projekt DEAL. The prospective observational study received a joint funding from AbbVie, Amgen, Alfasigma, Almirall, Biogen, BMS, Chugai, Fresenius Kabi, Galapagos, GA Generic Assays, GSK, Hexal, Horizon Therapeutics, Lilly, Medac, Mundipharma, Novartis, Pfizer, Roche, Sanofi-Genzyme, and UCB. The authors declared having no conflicts of interest. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
Yahoo
2 days ago
- Yahoo
Natera initiates trial of Signatera test for breast cancer
Natera has announced the initiation of the Phase II TEODOR trial of its Signatera test aimed at replacing chemotherapy with endocrine therapy before surgery in certain breast cancer patients. The multicentre, randomised controlled trial (RCT) focuses on women with hormone receptor-positive (HR+), human epidermal growth factor receptor 2 (HER2)-negative breast cancer who are responsive to endocrine treatment and test negative with Signatera. Academic research organisation Austrian Breast & Colorectal Cancer Study Group sponsored the trial, which plans to enrol 250 subjects across 15 Austrian sites. This trial seeks to assess the endocrine therapy's efficacy in comparison to chemotherapy in those who are Signatera-negative, to minimise the use of pre-operative chemotherapy and its associated side effects. After receiving an endocrine therapy course for four weeks, subjects who remain Signatera-negative and exhibit a favourable response as per the Ki-67 proliferation index measurement are set to be randomised to continue with endocrine therapy or chemotherapy. The primary goal of the TEODOR trial is the response rate to neoadjuvant therapy, gauged by pathological complete response (pCR) and modified Preoperative Endocrine Prognostic Index (PEPI) score, across endocrine and chemotherapy trial arms. Secondary goals encompass long-term effects such as recurrence of breast cancer and overall survival rates. Signatera is a custom-built blood test for identifying molecular residual disease (MRD) in the form of circulating tumour DNA. Natera oncology medical director Angel Rodriguez said: 'With the TEODOR trial, our goal is to identify patients who may be able to safely forgo chemotherapy. 'We are proud to collaborate with ABCSG on this important trial, and we hope this study will support the role of Signatera in guiding neoadjuvant therapy in breast cancer.' The test is covered by Medicare for those with stage IIb and higher breast cancer. In May 2025, Natera announced outcomes from a study assessing the Signatera MRD test in those with soft tissue and bone sarcomas. "Natera initiates trial of Signatera test for breast cancer" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
